# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
All resolutions voted with a large majority according to Board of Directors recommendationsCompany renamed Phaxiam Therapeutics...
In February, Erytech Pharma SA (NASDAQ: ERYP) announced its proposed combi
Gainers Audacy, Inc. (NYSE: AUD) gained 75.8% to $0.2337 in pre-market trading after gaining around 16% on Wednesday. The co...
Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaborat...